# Xenon Pharmaceuticals Inc.: Form 8-K, filed Aug 8, 2023

- Company: [Xenon Pharmaceuticals Inc.](/companies/xene.md) (CIK 1582313)
- Form: 8-K
- Filed: 2023-08-08
- Accepted by EDGAR: Aug 8, 2023, 16:07 ET
- Period: 2023-08-08
- Accession: 0000950170-23-039782
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1582313/000095017023039782/xene-20230808.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1582313/000095017023039782/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1582313/000095017023039782/xene-20230808.htm

Filed Aug 8, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-039782. Last ingested by Listed: Nov 6, 2026, 13:10 ET. No prices; not investment advice.